SKF-82,958

From WikiMD's WELLNESSPEDIA

SKF-82,958 is a synthetic compound of the benzazepine chemical class which acts as a D1 receptor full agonist. SKF-82,958 has been used in scientific research to study the role of the D1 receptor in the brain. It is also used as a reference drug in the development of new pharmaceuticals.

Chemistry[edit]

SKF-82,958 is a member of the benzazepine class of compounds. It is a synthetic compound, meaning it is not found naturally in the environment. The chemical structure of SKF-82,958 is characterized by a benzazepine core, which is a seven-membered ring fused to a benzene ring.

Pharmacology[edit]

SKF-82,958 acts as a full agonist at the D1 receptor, one of the five subtypes of the dopamine receptor. An agonist is a substance that initiates a physiological response when combined with a receptor. In the case of SKF-82,958, the physiological response is initiated when the compound binds to the D1 receptor.

Uses in Research[edit]

SKF-82,958 has been used in scientific research to study the role of the D1 receptor in the brain. It is often used as a reference drug in the development of new pharmaceuticals. The compound's ability to bind to the D1 receptor and initiate a physiological response makes it a useful tool in the study of this receptor and its role in various neurological and psychiatric disorders.

See Also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.